GlobalData on MSN16h
Japan’s MHLW approves CSL Behring’s Andembry to stop HAE attacks
CSL Behring KK has gained approval from Japan's Ministry of Health, Labour and Welfare (MHLW) to manufacture and market ...
Clarksburg-Weston WDTV on MSN22h
WVU Medicine helps gives answers to a West Virginia Women who has a rare illness
Twenty-seven-year-old Daniela powers a native of West Virginia. Since 20222, she has experiencing unexplained rashes and ...
FiercePharma17h
Regulatory tracker: BMS' Breyanzi wins NICE backing in 2nd-line large B-cell lymphoma
The CLDN18.2 biomarker is expressed by about 35% of Chinese stomach cancer patients, according to Astellas. The approval was backed by two global phase 3 trials, dubbed Glow and Spotlight ...